The relationship between infliximab concentrations, antibodies to infliximab and disease activity in Crohn's disease

OBJECTIVE: Although low infliximab trough concentrations and antibodies to infliximab (ATI) are associated with poor outcomes in patients with Crohn's disease (CD), the clinical relevance of ATI in patients with adequate infliximab concentrations is uncertain. We evaluated this question using a...

Descripción completa

Detalles Bibliográficos
Autores principales: Vande Casteele, Niels, Khanna, Reena, Levesque, Barrett G, Stitt, Larry, Zou, G Y, Singh, Sharat, Lockton, Steve, Hauenstein, Scott, Ohrmund, Linda, Greenberg, Gordon R, Rutgeerts, Paul J, Gils, Ann, Sandborn, William J, Vermeire, Séverine, Feagan, Brian G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2015
Materias:
Inflammatory Bowel Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602247/
https://www.ncbi.nlm.nih.gov/pubmed/25336114
http://dx.doi.org/10.1136/gutjnl-2014-307883

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602247/
https://www.ncbi.nlm.nih.gov/pubmed/25336114
http://dx.doi.org/10.1136/gutjnl-2014-307883

Ejemplares similares